{"id":237068,"date":"2026-01-08T10:45:19","date_gmt":"2026-01-08T15:45:19","guid":{"rendered":"https:\/\/ibkrcampus.com\/campus\/?p=237068"},"modified":"2026-01-09T04:40:41","modified_gmt":"2026-01-09T09:40:41","slug":"the-q1-investor-conference-calendar-what-matters-and-why","status":"publish","type":"post","link":"https:\/\/www.interactivebrokers.com\/campus\/traders-insight\/securities\/macro\/the-q1-investor-conference-calendar-what-matters-and-why\/","title":{"rendered":"The Q1 Investor Conference Calendar: What Matters and Why"},"content":{"rendered":"\n

We\u2019re hitting the ground running in 2026. The first weekend of the new year was chock-full of geopolitical intrigue, which has (so far) been bullish for domestic Energy-sector stocks. <\/p>\n\n\n\n

But don\u2019t turn your back on the AI mega-trend. Major gains have been seen in tech, particularly outside the U.S. It hits on a central price-action theme from 2025<\/a>: outperformance among international equities. Does that trend keep up this year? Investors will surely get plenty of opinions at conferences in the weeks ahead.<\/p>\n\n\n\n

Tech Took Center Stage at CES<\/h3>\n\n\n\n

Indeed, it\u2019s a jam-packed slate of Q1 corporate gatherings. This week\u2019s headliner was CES (formerly the Consumer Electronics Show), held in Las Vegas. NVIDIA (NVDA) CEO Jensen Huang gave the keynote on Monday afternoon, after what has been a lackluster few months for NVDA shares. <\/p>\n\n\n\n

Competition is the word of the moment within the semiconductor space. Alphabet\u2019s (GOOGL) in-house chips and rising demand for Broadcom\u2019s (AVGO) custom GPUs and TPUs have put the heat on the world\u2019s most valuable company. Key clues about the future of AI and the risks that could emerge for the broader Information Technology sector could be revealed at upcoming conferences.<\/p>\n\n\n\n

Health Care in the Spotlight<\/h3>\n\n\n\n

And then there\u2019s Health Care. Next week, JPMorgan (JPM) hosts its Annual Health Care Conference\u2014among the most highly anticipated events of the year. Large-cap pharma continues to deal with a volatile, changing regulatory environment, while biotech stocks have been on a heater since the middle of 2025. Insurance providers, meanwhile, appear to be in the Trump administration\u2019s crosshairs. It is a midterm election year, mind you.<\/p>\n\n\n\n

Banks: Quiet Winners, Global Reach<\/h3>\n\n\n\n

Speaking of JPM, the big banks were quiet winners last year. Uptrending stock and bond markets, a solid year for IPOs, and booming M&A activity<\/a> were catalysts. Citigroup (C) led, up almost 70% in 2025, while Wells Fargo (WFC) and JPM returned about 35%, dividends included. Financial institutions around the world stood out, too. <\/p>\n\n\n\n

We don\u2019t talk about them much, but HSBC, Allianz, Banco Santander, UBS, BBVA, BNP Paribas, and Barclays collectively tallied massive annual returns. So, we\u2019ll mention a handful of overseas Financial Services conferences in today\u2019s Q1 outlook.<\/p>\n\n\n\n

Metals & Mining Ride Strong Tailwinds<\/h3>\n\n\n\n

Maybe the most upbeat conference ballrooms will be those occupied by CEOs and CFOs from the Metals & Mining industry. Gold and silver posted their best years since 1979, with incredible upside price action from August through mid-December. A year-end stumble has already been partly reversed in the first handful of 2026 sessions. <\/p>\n\n\n\n

Record-high spot metal prices, low energy costs, and steady labor expenses appear to be the ideal recipe for the miners.<\/p>\n\n\n\n

Asset Allocation Questions Grow Louder<\/h3>\n\n\n\n

Zooming out, investors will have their ears out for tidbits regarding asset allocation in light of recent trends:<\/p>\n\n\n\n